141 related articles for article (PubMed ID: 24029832)
1. Novel compound heterozygous mutations resulting in cone dystrophy with supernormal rod response.
Lenis TL; Dhrami-Gavazi E; Lee W; Mukkamala SK; Tabacaru MR; Yannuzzi L; Gouras P; Tsang SH
JAMA Ophthalmol; 2013 Nov; 131(11):1482-5. PubMed ID: 24029832
[No Abstract] [Full Text] [Related]
2. Coexistence of KCNV2 associated cone dystrophy with supernormal rod electroretinogram and MFRP related oculopathy in a Turkish family.
Ritter M; Vodopiutz J; Lechner S; Moser E; Schmidt-Erfurth UM; Janecke AR
Br J Ophthalmol; 2013 Feb; 97(2):169-73. PubMed ID: 23143909
[TBL] [Abstract][Full Text] [Related]
3. Novel biallelic loss-of-function KCNV2 variants in cone dystrophy with supernormal rod responses.
Kutsuma T; Katagiri S; Hayashi T; Yoshitake K; Iejima D; Gekka T; Kohzaki K; Mizobuchi K; Baba Y; Terauchi R; Matsuura T; Ueno S; Iwata T; Nakano T
Doc Ophthalmol; 2019 Jun; 138(3):229-239. PubMed ID: 30877594
[TBL] [Abstract][Full Text] [Related]
4. Autosomal recessive cone-rod dystrophy associated with compound heterozygous mutations in the EYS gene.
Katagiri S; Akahori M; Hayashi T; Yoshitake K; Gekka T; Ikeo K; Tsuneoka H; Iwata T
Doc Ophthalmol; 2014 Jun; 128(3):211-7. PubMed ID: 24652164
[TBL] [Abstract][Full Text] [Related]
5. A novel KCNV2 mutation in a patient taking hydroxychloroquine associated with cone dystrophy with supernormal rod response.
Liu PK; Ryu J; Yeh LK; Chen KJ; Tsang SH; Liu L; Wang NK
Ophthalmic Genet; 2021 Aug; 42(4):458-463. PubMed ID: 33960280
[TBL] [Abstract][Full Text] [Related]
6. Cone dystrophy with supernormal rod response: novel KCNV2 mutations in an underdiagnosed phenotype.
Zelinger L; Wissinger B; Eli D; Kohl S; Sharon D; Banin E
Ophthalmology; 2013 Nov; 120(11):2338-43. PubMed ID: 23725738
[TBL] [Abstract][Full Text] [Related]
7. Retinitis pigmentosa and bilateral cystoid macular oedema in a patient heterozygous for the RIM1 mutation previously associated with cone-rod dystrophy 7.
Warwick AN; Shawkat F; Lotery AJ
Ophthalmic Genet; 2017; 38(2):178-182. PubMed ID: 27176872
[TBL] [Abstract][Full Text] [Related]
8. Cone dystrophy with "supernormal" rod ERG: psychophysical testing shows comparable rod and cone temporal sensitivity losses with no gain in rod function.
Stockman A; Henning GB; Michaelides M; Moore AT; Webster AR; Cammack J; Ripamonti C
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):832-40. PubMed ID: 24370833
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause "cone dystrophy with supernormal rod electroretinogram" in humans.
Wu H; Cowing JA; Michaelides M; Wilkie SE; Jeffery G; Jenkins SA; Mester V; Bird AC; Robson AG; Holder GE; Moore AT; Hunt DM; Webster AR
Am J Hum Genet; 2006 Sep; 79(3):574-9. PubMed ID: 16909397
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characteristics including in vivo cone photoreceptor mosaic in KCNV2-related "cone dystrophy with supernormal rod electroretinogram".
Vincent A; Wright T; Garcia-Sanchez Y; Kisilak M; Campbell M; Westall C; Héon E
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):898-908. PubMed ID: 23221069
[TBL] [Abstract][Full Text] [Related]
11. Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy.
Thiadens AA; Phan TM; Zekveld-Vroon RC; Leroy BP; van den Born LI; Hoyng CB; Klaver CC; ; Roosing S; Pott JW; van Schooneveld MJ; van Moll-Ramirez N; van Genderen MM; Boon CJ; den Hollander AI; Bergen AA; De Baere E; Cremers FP; Lotery AJ
Ophthalmology; 2012 Apr; 119(4):819-26. PubMed ID: 22264887
[TBL] [Abstract][Full Text] [Related]
12. Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance.
Kameya S; Fujinami K; Ueno S; Hayashi T; Kuniyoshi K; Ideta R; Kikuchi S; Kubota D; Yoshitake K; Katagiri S; Sakuramoto H; Kominami T; Terasaki H; Yang L; Fujinami-Yokokawa Y; Liu X; Arno G; Pontikos N; Miyake Y; Iwata T; Tsunoda K;
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3432-3446. PubMed ID: 31390656
[TBL] [Abstract][Full Text] [Related]
13. Analysis of retinal structure and function in cone dystrophy with supernormal rod response.
Abdelkader E; Yasir ZH; Khan AM; Raddadi O; Khandekar R; Alateeq N; Nowilaty S; AlShahrani N; Schatz P
Doc Ophthalmol; 2020 Aug; 141(1):23-32. PubMed ID: 31960170
[TBL] [Abstract][Full Text] [Related]
14. Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease.
Xi Q; Li L; Traboulsi EI; Wang QK
Mol Vis; 2009; 15():638-45. PubMed ID: 19352439
[TBL] [Abstract][Full Text] [Related]
15. Homozygosity mapping in patients with cone-rod dystrophy: novel mutations and clinical characterizations.
Littink KW; Koenekoop RK; van den Born LI; Collin RW; Moruz L; Veltman JA; Roosing S; Zonneveld MN; Omar A; Darvish M; Lopez I; Kroes HY; van Genderen MM; Hoyng CB; Rohrschneider K; van Schooneveld MJ; Cremers FP; den Hollander AI
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5943-51. PubMed ID: 20554613
[TBL] [Abstract][Full Text] [Related]
16. Autosomal Dominant Retinal Dystrophy With Electronegative Waveform Associated With a Novel RAX2 Mutation.
Yang P; Chiang PW; Weleber RG; Pennesi ME
JAMA Ophthalmol; 2015 Jun; 133(6):653-61. PubMed ID: 25789692
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic Features of Oguchi Disease and Retinitis Pigmentosa in Patients with S-Antigen Mutations: A Long-Term Follow-up Study.
Nishiguchi KM; Ikeda Y; Fujita K; Kunikata H; Akiho M; Hashimoto K; Hosono K; Kurata K; Koyanagi Y; Akiyama M; Suzuki T; Kawasaki R; Wada Y; Hotta Y; Sonoda KH; Murakami A; Nakazawa M; Nakazawa T; Abe T
Ophthalmology; 2019 Nov; 126(11):1557-1566. PubMed ID: 31257036
[TBL] [Abstract][Full Text] [Related]
18. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
[TBL] [Abstract][Full Text] [Related]
19. SPATA7: Evolving phenotype from cone-rod dystrophy to retinitis pigmentosa.
Matsui R; McGuigan Iii DB; Gruzensky ML; Aleman TS; Schwartz SB; Sumaroka A; Koenekoop RK; Cideciyan AV; Jacobson SG
Ophthalmic Genet; 2016 Sep; 37(3):333-8. PubMed ID: 26854980
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant retinitis pigmentosa with intrafamilial variability and incomplete penetrance in two families carrying mutations in PRPF8.
Maubaret CG; Vaclavik V; Mukhopadhyay R; Waseem NH; Churchill A; Holder GE; Moore AT; Bhattacharya SS; Webster AR
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9304-9. PubMed ID: 22039234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
